Nissui Pharmaceutical Co., Ltd.

TSE:4550 Stock Report

Market Cap: JP¥16.9b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Nissui Pharmaceutical Management

Management criteria checks 1/4

Key information

Tokuya Ono

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure8.4yrs
CEO ownershipn/a
Management average tenure1.8yrs
Board average tenure8.4yrs

Recent management updates

Recent updates

CEO

Tokuya Ono (60 yo)

8.4yrs

Tenure

Mr. Tokuya Ono has been Executive President at Nissui Pharmaceutical Co., Ltd., since June 2014, and serves as its Chief Executive Officer. He served as Chief of Business Planning and Promotion Office at N...

Leadership Team

NamePositionTenureCompensationOwnership
Tokuya Ono
CEO, President8.4yrsno datano data
Tatsuo Ishii
CFO, Executive Officer & Head of Corporate Headquarterless than a yearno datano data
Yuki Okagaki
Manager of Accounting Department and Executive Officerno datano datano data
Shin Saito
Executive Officerless than a yearno data0%
¥ 0
Seiichi Tanitsu
GM of Business Support & Investor Relations Management Planning Dept14.6yrsno datano data
Seiji Tanaka
Exe. Officer and GM of Clinical Diagnosticno datano datano data
Chieko Yamazaki
Executive Officer & GM of Sales Support Departmentno datano datano data
Yuichi Oku
Executive Officer and GM of Research1.8yrsno datano data
Yoshihiro Okada
Executive Officer and Manager of Diagnostic Product Sales Departmentno datano datano data

1.8yrs

Average Tenure

60yo

Average Age

Experienced Management: 4550's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Tokuya Ono
CEO, President11.4yrsno datano data
Shin Saito
Executive Officer3.4yrsno data0%
¥ 0
Seiichi Tanitsu
GM of Business Support & Investor Relations Management Planning Dept8.4yrsno datano data
Takeshi Tayama
Outside Corporate Auditor15.4yrsno datano data
Eiichi Shibasaki
Independent Outside Director13.4yrsno data0%
¥ 0
Shigetaka Misaka
Advisor & Outside Corporate Auditor1.4yrsno datano data
Wahei Toki
Full-Time Auditor8.4yrsno data0%
¥ 0
Kazunori Kato
Independent Outside Director6.4yrsno datano data
Junichiro Yonekura
Independent Outside Director2.8yrsno datano data

8.4yrs

Average Tenure

60yo

Average Age

Experienced Board: 4550's board of directors are considered experienced (8.4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/11/16 10:22
End of Day Share Price 2022/11/10 00:00
Earnings2022/09/30
Annual Earnings2022/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nissui Pharmaceutical Co., Ltd. is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullCompany Forecast